Stay updated on Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial

Sign up to get notified when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no substantive changes to the study details or core content observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-17T01:22:07.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1; removed the funding-status notice and the prior Revision: v3.4.0 notice.
    Difference
    0.1%
    Check dated 2026-02-09T23:01:12.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added at the top of the page. The notice states that the NIH Clinical Center is open and directs users to cc.nih.gov and opm.gov for status updates.
    Difference
    0.1%
    Check dated 2026-02-02T20:32:14.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Added a glossary toggle (Show glossary) and updated metadata to include Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed the older lowercase version of the QC note and the previous Revision: v3.3.4 label.
    Difference
    0.1%
    Check dated 2026-01-26T21:02:41.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4 in the page footer.
    Difference
    0.0%
    Check dated 2026-01-19T21:43:18.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    A consolidated 'Locations' section listing all study sites by country and city was added. The page's location subsections were reorganized to a single listing.
    Difference
    3%
    Check dated 2025-12-22T01:54:47.000Z thumbnail image

Stay in the know with updates to Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.